Moreover, it was observed that resistin increased P-gp mRNA as well as protein levels (Fig. 3f, g), suggesting that resistin plays a role in chemotherapeutic outcome in melanoma, in part, via increasing the expression of P-gp, while leptin-mediated impaired response of cancer cells to DTIC is independent of P-gp activity. The gene discussed is RETN; the disease is cancer.